Details of the Drug

General Information of Drug (ID: DMD5CXA)

Drug Name

Atpenin B

Synonyms

Atpenin A4; Atpenin A5; NBRI-23477A; NBRI-23477B; Atpenins program (cancer), Meiji Seika Kaisha; Mitochondrial complex II inhibitors (cancer), Meiji Seika Kaisha; Succinate-ubiquinone oxidoreductase inhibitors (cancer); Succinate-ubiquinone oxidoreductase inhibitors (cancer), Meiji Seika Kaisha

Indication

Disease Entry	ICD 11	Status	REF
Solid tumour/cancer	2A00-2F9Z	Investigative	[1]
------------------------------------------------------------------------------------

Drug Type

Small molecular drug

Structure

3D MOL

2D MOL

Chemical Identifiers

Formula: C15H23NO5
Canonical SMILES: CCC(C)CC(C)C(=O)C1=C(C(=C(NC1=O)OC)OC)O
InChI: 1S/C15H23NO5/c1-6-8(2)7-9(3)11(17)10-12(18)13(20-4)15(21-5)16-14(10)19/h8-9H,6-7H2,1-5H3,(H2,16,18,19)/t8-,9+/m1/s1
InChIKey: UQWHXKHYKUVKKD-BDAKNGLRSA-N

Cross-matching ID

PubChem CID: 54676869
CAS Number: 119509-26-1
DrugBank ID: DB04631
TTD ID: D0P7BQ

References

1	The ChEMBL database in 2017. Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954.